InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by BUCHI J KEVIN, Director. Insider active across 3 companies, notably Ziopharm Oncology INC. Aggregated, 9 filings have been logged. The latest transaction was filed on 28 December 2021 — U. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
35,406 shares
Class A Common Stock
SEC:0001209191-22-028155:0·
€157,5234,666 shares@ €33.7598100.0% of flow
Common Stock
SEC:0001399529-21-000195·
€157,5234,666 shares@ €33.759850.0% of flow
Common Stock
SEC:0001399529-21-000195:0·
4,666 shares
Common Stock
SEC:0001399529-21-000106·
4,666 shares
Common Stock
SEC:0001399529-21-000106:0·
46,218 shares
Class A Common Stock
SEC:0001209191-21-030806·
46,218 shares
Class A Common Stock
SEC:0001209191-21-030806:0·
4,167 shares
Common Stock
SEC:0001209191-21-030738·
04,167 shares0
Common Stock
SEC:0001209191-21-030738:0·
9 of 9 declarations
About BUCHI J KEVIN
Kevin J. Buchi is a Board Member at ZioPharm Oncology Inc, Amneal Pharmaceuticals, Inc., and Dicerna Pharmaceuticals Inc. With experience in the pharmaceutical sector, he contributes to the governance and strategy of the companies. His role is essential in guiding decisions that foster innovation and growth.
